SCHEMBL754294

SCHEMBL754294

COc1cc(C(=O)O)ccc1COc1ccc([C@@H](C)[C@@](O)(c2cnc(C)cn2)C(F)(F)F)c(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.43
NR4A2 P43354 3/20 0.37
ALDH1A1 P00352 2/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MRGPRX4 Q96LA9 4/20 0.36
CSNK2A2 P19784 2/20 0.36
CSNK2A1 P68400 2/20 0.36
TSHR P16473 2/20 0.35
KDM5A P29375 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
NR1H4 Q96RI1 2/20 0.35
CHRM3 P20309 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HPGD P15428 1/20 0.35
ROCK2 O75116 1/20 0.34
ROCK1 Q13464 1/20 0.34
NR4A1 P22736 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL479990 1.00 HDAC8 (0.43) HDAC8NR4A2ALDH1A1GAAMAPT
SCHEMBL15800814 0.94 HDAC8 (0.42) HDAC8NR4A2ALDH1A1GAAMAPT
SCHEMBL752895 0.93 HDAC8 (0.44) HDAC8ALDH1A1GAAMAPTL3MBTL1
SCHEMBL479809 0.93 HDAC8 (0.44) HDAC8ALDH1A1GAAMAPTL3MBTL1
SCHEMBL753119 0.92 NR4A2 (0.44) NR4A2MRGPRX4KDM5AKDM4CKDM5B
SCHEMBL479913 0.92 NR4A2 (0.44) NR4A2MRGPRX4KDM5AKDM4CKDM5B
SCHEMBL733155 0.88 RXRA (0.44) NR4A2MRGPRX4NR1H4
SCHEMBL733547 0.88 RXRA (0.44) NR4A2MRGPRX4NR1H4
SCHEMBL479988 0.88 RXRA (0.44) NR4A2MRGPRX4NR1H4
SCHEMBL479949 0.86 ALDH1A1 (0.39) ALDH1A1L3MBTL1MRGPRX4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 HDAC8 1978/4885NR4A2 220/4885ALDH1A1 317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.